• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
YAN Qiang, WU Shumin, NI Lili, XIE Yusuo, GAO Liuzhou, HUANG Wenlong, LIU Yingjie, HU Guoqiang. Synthesis and antitumor activity of C-3 thiazolo ［3, 2-b］［1, 2, 4］triazole-substituted pefloxacin derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(5): 548-551. DOI: 10.11665/j.issn.1000-5048.20150505
Citation: YAN Qiang, WU Shumin, NI Lili, XIE Yusuo, GAO Liuzhou, HUANG Wenlong, LIU Yingjie, HU Guoqiang. Synthesis and antitumor activity of C-3 thiazolo ［3, 2-b］［1, 2, 4］triazole-substituted pefloxacin derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(5): 548-551. DOI: 10.11665/j.issn.1000-5048.20150505
shu

Synthesis and antitumor activity of C-3 thiazolo ［3, 2-b］［1, 2, 4］triazole-substituted pefloxacin derivatives

More Information
    Graphical Abstract
    • Abstract
  • To search for fluoroquinolones(FQs)with antitumor activity, the C-3 carboxylic acid group of pefloxacin( 1 )was replaced by fused heterocyclic core, and twelve novel thiazolo［3, 2-b］［1, 2, 4］triazole heterocycles( 6a - 6l )were designed and synthesized. The structures of target compounds were characterized by elemental analysis and spectral data. The results of the in vitro antiproliferative effect on SMMC-7721, L1210 and HL60 cell lines showed that the title compounds exhibited more significant antitumor activity than both of the pefloxacin and the corresponding opening-ring intermediates( 5a - 5l ). Among them, the target compounds which possess a benzene ring bearing a hydroxyl group( 6e )or a fluorine atom( 6j )exhibited more potent antiproliferative effect on SMMC-7721 cells than other compounds. Therefore, the antitumor fluoroquinolones can be designed by replacing the C-3 carboxylic acid group of fluoroquinolones with the thiazolo ［3, 2-b］［1, 2, 4］ triazole moiety.
    • FullText(HTML)
    • References (9)
  • [1]
    Guo ZR.Strategy of molecular drug design:pharmacophore and scaffold hopping[J].Chin J Med Chem(中国药物化学杂志),2008,18(2):147-157.
    [2]
    Mugnaini C,Pasquini S,Corelli F.The 4-quinolone-3-carboxylic acid motif as a multivalent scaffold in medicinal chemistry[J].Curr Med Chem,2009,16(14):1746-1767.
    [3]
    Peng XM,Cai GX,Zhou CH.Recent developments in azole compounds as antibacterial and antifungal agents[J].Curr Top Med Chem,2013,13(16):1963-2010.
    [4]
    Sun YS,Xu QJ,Hou LL,et al. Synthesis antitumor activity of fluoroquinolone C-3 bioisosteres(IV): s-triazole-oxadiazole methylsulfide Mannich-base derivatives[J].J China Pharm Univ(中国药科大学学报),2014,45(1):39-42.
    [5]
    Xu QJ,Hou LL,Wu ZF,et al. Synthesis antitumor activity of fluoroquinolone C-3 bioisosteres(III): s-triazole-oxadiazole methylsulfide derivatives from pefloxacin[J].J China Pharm Univ(中国药科大学学报),2013,44(6):511-514.
    [6]
    You QD,Li ZY,Huang CH,et al. Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification[J].J Med Chem,2009,52(18):5649-5661.
    [7]
    Husain A, Rashid M, Mishra R, et al. Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus:design and synthesis as anticancer agents[J].Bioorg Med Chem Lett,2012,22(17):5438-5444.
    [8]
    Xie YS,Gao LZ,Yan Q,et al. Synthesis and antitumor activity of fluoroquinolone C-3 isosteres(VIII):s-triazole sulfide-one thiosemicarbazone derivatives from pefloxacin[J].J China Pharm Univ(中国药科大学学报),2015,46(4):416-420.
    [9]
    Xu QJ,Hou LL,Wu XK,et al. Synthesis and antitumor activity of ciprofloquinolone bis-(C3 /C7 hydrazone)s[J].J China Pharm Univ(中国药科大学学报),2013,44(1):35-38.
    • Related Articles

  • Related Articles

    [1]MU Yao, ZHAO Huimin, LIU Haochen, LIU Xiaoquan. Advances in drug development for Alzheimer’s disease[J]. Journal of China Pharmaceutical University, 2024, 55(6): 816-825. DOI: 10.11665/j.issn.1000-5048.2024010202
    [2]XING Xuyang, WANG Xiaochun, HE Wei. Advances in research on tumor immunotherapy and its drug development[J]. Journal of China Pharmaceutical University, 2021, 52(1): 10-19. DOI: 10.11665/j.issn.1000-5048.20210102
    [3]MEI Jiahao, HONG Ze, WANG Chen. Advances of drugs in targeting cGAS-STING signaling pathway[J]. Journal of China Pharmaceutical University, 2020, 51(3): 249-259. DOI: 10.11665/j.issn.1000-5048.20200301
    [4]CHEN Xing, KANG Yang, WU Jun. Advances in biodegradable functional polymers based protein drug delivery system[J]. Journal of China Pharmaceutical University, 2017, 48(2): 142-149. DOI: 10.11665/j.issn.1000-5048.20170203
    [5]SU Zhigui, MO Ran, ZHANG Can. Advances of nano-drug delivery systems overcoming the physiological and pathological barriers of tumor[J]. Journal of China Pharmaceutical University, 2015, 46(1): 28-39. DOI: 10.11665/j.issn.1000-5048.20150103
    [6]YIN Lei, WANG Ying, CHEN Song, GAO Xiangdong. Advances of glucagon-like peptide-1 receptor agonists in the treatment of nervous system diseases[J]. Journal of China Pharmaceutical University, 2014, 45(4): 383-391. DOI: 10.11665/j.issn.1000-5048.20140401
    [7]WANG Yazhe, ZHOU Jianping, DING Yang, WANG Wei. Advances in research of biomimetic drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(3): 267-273. DOI: 10.11665/j.issn.1000-5048.20140303
    [8]WANG Juan, LIAO Hong. Advances in drug research and development through directed differentiation of stem cells[J]. Journal of China Pharmaceutical University, 2011, 42(3): 193-197.
    [9]XU Si-sheng, ZHANG Hui-bin, ZHOU Jin-pei, HUANG Jian-jun. Advances of new antidiabetic drugs[J]. Journal of China Pharmaceutical University, 2011, 42(2): 97-106.
    [10]Advances and Prospects of Drug Discovery and Development Zhang Yihua, Peng Sixun, Hua Weiyi[J]. Journal of China Pharmaceutical University, 1999, (2): 75-80.

  • Cited by

    Periodical cited type(6)

    1. 金伟斌，陈礼峰，唐倩倩，顾晓风. 顶空气相色谱法测定生脉注射液中甲醛和乙醛的含量. 中国合理用药探索. 2022(06): 115-120 .
    2. 李浩宇，唐宝强，何东升，涂家生. 气相色谱法测定药用辅料聚西托醇1000中的残留杂质. 中国药科大学学报. 2022(03): 293-299 . 本站查看
    3. 王贺，钱利武，阚红卫. 药用辅料监管法规、质量标准现状分析及应对措施. 中南药学. 2022(08): 1937-1941 .
    4. 庞丽然，贺丞，杜力，刘国芳. 重组蛋白中吐温80含量硫氰酸铵钴显色检测法的改进及验证. 中国生物制品学杂志. 2021(09): 1111-1113+1119 .
    5. 郑永强，付俊伟，朱慧敏，陶晓军. 一种用于实现脑靶向的负载长春新碱抗肿瘤纳米药物制剂的制备及表征. 肿瘤药学. 2021(05): 547-553 .
    6. 黄婧，吴宏伟. 依诺沙星滴眼液辅料及药包材相容性研究. 中国现代应用药学. 2021(22): 2802-2806 .

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML
    Article views (992) PDF downloads (1920) Cited by(8)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：304011

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return